David Bouchey
Stock Analyst at Aegis Capital
(0.13)
# 4,385
Out of 5,031 analysts
8
Total ratings
22.22%
Success rate
-44.05%
Average return
Main Sectors:
Stocks Rated by David Bouchey
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
SBFM Sunshine Biopharma | Reiterates: Buy | $7 | $2.09 | +234.93% | 3 | Oct 8, 2025 | |
AEON AEON Biopharma | Reiterates: Buy | $7.2 | $1.10 | +554.55% | 1 | Oct 8, 2025 | |
STSS Sharps Technology | Initiates: Buy | $105,600 | $4.72 | +2,237,188.14% | 1 | May 9, 2023 | |
IINN Inspira Technologies Oxy B.H.N. | Maintains: Buy | $10 → $13 | $1.10 | +1,081.82% | 1 | Jan 25, 2023 | |
RMTI Rockwell Medical | Downgrades: Outperform | $121 | $1.17 | +10,241.88% | 2 | Oct 19, 2018 |
Sunshine Biopharma
Oct 8, 2025
Reiterates: Buy
Price Target: $7
Current: $2.09
Upside: +234.93%
AEON Biopharma
Oct 8, 2025
Reiterates: Buy
Price Target: $7.2
Current: $1.10
Upside: +554.55%
Sharps Technology
May 9, 2023
Initiates: Buy
Price Target: $105,600
Current: $4.72
Upside: +2,237,188.14%
Inspira Technologies Oxy B.H.N.
Jan 25, 2023
Maintains: Buy
Price Target: $10 → $13
Current: $1.10
Upside: +1,081.82%
Rockwell Medical
Oct 19, 2018
Downgrades: Outperform
Price Target: $121
Current: $1.17
Upside: +10,241.88%